SAGE THERAPEUTICS INC shareholders Q2 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Walleye Capital LLC 3,400$159,8680.00%
OSAIC HOLDINGS, INC. 9,840$462,6400.00%
Focused Wealth Management, Inc 100$4,7020.00%
TD ASSET MANAGEMENT INC 12,074$567,7190.00%
RAYMOND JAMES & ASSOCIATES 13,435$631,7140.00%
UBS Group AG 80,381$3,779,5150.00%
ALLIANCEBERNSTEIN L.P. 61,100$2,872,9220.00%
Kistler-Tiffany Companies, LLC 100$4,7020.00%
TWO SIGMA INVESTMENTS, LP 4,832$227,2010.00%
AQR Capital Management 11,125$523,0980.00%
BANK OF AMERICA CORP /DE/ 135,944$6,392,0870.00%
WELLS FARGO & COMPANY/MN 54,429$2,559,2520.00%
Legal & General Group Plc 57,881$2,721,5640.00%
JANUS HENDERSON GROUP PLC 26,195$1,231,3000.00%
NEW YORK STATE COMMON RETIREMENT FUND 22,309$1,0490.00%
NISA INVESTMENT ADVISORS, LLC 2,029$95,4040.00%
STRS OHIO 7,300$3430.00%
CITIGROUP INC 20,000$940,4000.00%
CITIGROUP INC 20,000$940,4000.00%
UBS ASSET MANAGEMENT AMERICAS LLC 44,077$1,849,4700.00%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.